Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial redox enzymes and membrane components encompass a broad range of proteins and lipids essential for cellular energy production and metabolic signaling. This category includes the five complexes of the electron transport chain (ETC) involved in oxidative phosphorylation, as well as membrane-bound proteins like the voltage-dependent anion channel (VDAC) and the adenine nucleotide translocator (ANT) [Nature Education, 2010; PMID: 23603395]. These components maintain the mitochondrial membrane potential and regulate the production of reactive oxygen species (ROS), which serve as critical signaling molecules but can also induce oxidative stress [PMID: 11085985]. Furthermore, the mitochondrial membrane serves as a scaffold for the BCL-2 family of proteins, which control the release of cytochrome c and the initiation of apoptosis [PMID: 18362888]. Dysregulation of these mitochondrial systems is implicated in a wide array of diseases, including neurodegenerative disorders (e.g., Parkinson's disease), cardiovascular diseases, and cancer, where mitochondrial metabolism is often reprogrammed to support rapid proliferation [Nature Reviews Drug Discovery, 2010; PMID: 21561349]. Pharmacological agents targeting these components include Complex I inhibitors like Metformin, Coenzyme Q10 analogs like Idebenone, and cardiolipin-stabilizing peptides like Elamipretide [PMID: 10839993; PMID: 24853131; PMID: 25405013]. Due to the fundamental role of mitochondria in all aerobic cells, therapeutic targeting requires careful consideration of systemic toxicity and potential off-target effects [PMID: 21561349]. This target name is considered a collective term for a broad group of mitochondrial proteins rather than a single specific therapeutic target.
Inhibition of the mitochondrial respiratory chain, modulation of mitochondrial membrane potential, stabilization of cardiolipin, and regulation of the mitochondrial permeability transition pore.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial redox enzymes and membrane components.